US FDA allows pharmacists to prescribe Pfizer's Covid-19 pill

Use of the Paxlovid pill jumped in recent weeks as infections rise. PHOTO: REUTERS

WASHINGTON (REUTERS) - The US Food and Drug Administration said on Wednesday (July 6) it had authorised state-licensed pharmacists to prescribe Pfizer Inc's Covid-19 pill to eligible patients to help improve access to the treatment.

The antiviral drug, Paxlovid, has been cleared for use and available for free in the United States since December, but fewer than half of the nearly 4 million courses distributed to pharmacies by the government so far have been administered.

Use of the pill, authorised for treatment of newly infected, at-risk people to prevent severe illness, has, however, jumped in recent weeks as infections rise.

"Since Paxlovid must be taken within five days after symptoms begin, authorising state-licensed pharmacists to prescribe Paxlovid could expand access to timely treatment for some patients," Dr Patrizia Cavazzoni, director for the FDA's Centre for Drug Evaluation and Research, said in a statement.

The agency said patients who tested positive for Covid-19 should bring their health records for the pharmacists to review for kidney and liver problems.

The American Medical Association (AMA) said in a statement prescribing decisions should be made by a doctor wherever possible.

"It (Paxlovid) is not for everyone and prescribing it requires knowledge of a patient's medical history, as well as clinical monitoring for side effects and follow-up care to determine whether a patient is improving," said AMA President Jack Resneck.

The FDA said pharmacists should refer the patients to a healthcare professional licensed to prescribe drugs if there is not sufficient information to assess kidney or liver function, or if modifications are needed due to a potential drug reaction.

Patients with reduced kidney function may need a lower dose of the treatment, the agency has said.

People in socially and economically disadvantaged regions are about half as likely to receive antiviral Covid-19 pills like Paxlovid than those in wealthier zip codes, a study by the US Centres for Disease Control and Prevention showed.

Join ST's Telegram channel and get the latest breaking news delivered to you.